Table 2 eGFR and estimated prevalence of decreased kidney function (eGFR <60 ml/min/1.73m²) among 7001 adults aged 18–79 in Germany 2008–2011 (DEGS1) according to the equation used

Overall

N = 7001

N = 4538

N = 1376

N = 1087

 MDRD

5.0 (4.3–5.7)

1.2 (0.8–1.5)

10.9 (8.8–13.1)

20.6 (17.3–23.9)

 CKD-EPIcre

3.8 (3.3–4.4)

0.4 (0.2–0.6)

7.8 (5.9–9.6)

19.2 (16.1–22.4)

 CKD-EPIcys

2.1 (1.7–2.5)

0.2 (0.1–0.3)

3.8 (2.3–5.4)

11.4 (8.9–13.9)

 CKD-EPIcrecys

2.3 (1.9–2.7)

0.2 (0.1–0.3)

3.8 (2.2–5.3)

12.8 (10.4–15.3)

 LM

6.0 (5.3–6.7)

0.5 (0.3–0.8)

11.7 (9.5–13.8)

31.4 (27.6–35.2)

 FAScre

6.9 (6.1–7.6)

0.5 (0.3–0.7)

11.9 (9.9–14.0)

38.4 (34.2–42.5)

Men

N = 3364

N = 2150

N = 667

N = 547

 MDRD

4.1 (3.3–4.8)

0.9 (0.5–1.3)

9.4 (6.4–12.4)

18.3 (14.4–22.1)

 CKD-EPIcre

3.6 (2.9–4.4)

0.5 (.0.2–0.8)

7.7 (4.9–10.4)

19.0 (14.9–23.1)

 CKD-EPIcys

1.6 (1.1–2.0)

0.2 (0.0–0.4)

2.8 (0.7–4.8)

8.6 (5.8–11.4)

 CKD-EPIcrecys

1.7 (1.3–2.2)

0.3 (0.1–0.5)

2.3 (0.3–4.3)

10.5 (7.6–13.4)

 LM

5.6 (4.8–6.5)

0.5 (0.3–0.8)

12.3 (9.1–15.5)

30.5 (25.6–35.5)

 FAScre

5.6 (4.7–6.4)

0.4 (0.1–0.6)

11.3 (8.2–14.4)

32.1 (27.0–37.1)

Women

N = 3637

N = 2388

N = 709

N = 540

 MDRD

5.9 (4.9–6.9)

1.5 (0.9–2.1)

12.4 (9.3–15.5)

22.6 (17.9–27.3)

 CKD-EPIcre

4.0 (3.2–4.8)

0.3 (0.1–0.6)

7.8 (5.3–10.4)

19.4 (14.9–24.0)

 CKD-EPIcys

2.6 (2.0–3.3)

0.1 (0.0–0.2)

4.9 (2.4–7.4)

13.8 (9.7–17.8)

 CKD-EPIcrecys

2.8 (2.2–3.4)

0.1 (0.0–0.1)

5.2 (2.8–7.6)

14.8 (10.9–18.7)

 LM

6.4 (5.4–7.3)

0.5 (0.2–0.9)

11.1 (8.2–14.0)

32.2 (27.2–37.1)

 FAScre

8.2 (7.1–9.2)

0.5 (0.2–0.9)

12.6 (9.7–15.5)

43.6 (38.3–49.0)